Performance of CarbaNP and CIM tests in OXA-48 carbapenemase-producing Enterobacteriaceae by Yıldız, Serap Süzük et al.
PERFORMANCE OF CARBANP AND CIM TESTS IN
OXA-48 CARBAPENEMASE-PRODUCING
ENTEROBACTERIACEAE
SERAP SÜZÜK YILDIZ1*, BANU KAS¸KATEPE2, HAVVA AVCIKÜÇÜK3 and
S¸ÜKRAN ÖZTÜRK2
1National Antimicrobial Resistance Laboratory, Public Health Institution of Turkey,
Ankara, Turkey
2Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Ankara University,
Ankara, Turkey
3Clinical Microbiology Laboratory, 29 Mayıs Statement Hospital, Ankara, Turkey
(Received: 2 January 2017; accepted: 24 February 2017)
This study applied two phenotypic tests, namely “Carbapenemase
Nordmann–Poirel” (CarbaNP) test and “Carbapenem Inactivation Method” (CIM),
against the isolates carrying the carbapenem resistance genes. The study included 83
carbapenem-resistant Enterobacteriaceae isolates producing oxacillinase-48
(OXA-48) and 30 carbapenem-sensitive Enterobacteriaceae isolates. Out of the total
isolates studied, 77 isolates (92.77%) were identiﬁed as Klebsiella pneumoniae and six
isolates (7.23%) were identiﬁed as Escherichia coli by Matrix Assisted Laser
Desorption Ionization-Time of Flight Mass Spectrometry. Polymerase chain reaction
(PCR) method used to detect resistance genes found that 74 isolates (89.16%)
produced OXA-48 carbapenemase, whereas nine isolates (10.84%) produced both
OXA-48 and New Delhi metallo-beta-lactamase-1 (NDM-1). The isolates producing
both OXA-48 and NDM-1 were found to be positive by both phenotypic tests. Among
isolates carrying only blaOXA-48 gene alone, nine isolates (13.04%) for CarbaNP test
and two isolates for CIM test (2.90%) displayed false negative results, respectively.
The sensitivity of CarbaNP and CIM tests was found to be 89.16% and 97.59%,
respectively, whereas the speciﬁcity was determined to be 100% for both tests. These
ﬁndings suggest that CarbaNP and CIM tests are useful tools to identify the
carbapenemase producers. Molecular methods like PCR are recommended to verify
false negative tests predicted to have OXA-48 activity.
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Introduction
The species included in the Enterobacteriaceae family are known to cause
community-acquired and nosocomial infections. Carbapenems have been com-
monly used in the treatment of infections caused by these bacteria, which possess
extended-spectrum beta-lactamases conferring resistance to many beta-lactam
antibiotics [1]. Carbapenemase-producing Enterobacteriaceae (CPE) result in
serious infections leading to an extension of the period of hospitalization and
increase in the mortality ratio. Therefore, monitoring of development of
resistance against carbapenems is necessary [2]. Carbapenemases contribute
signiﬁcantly to the development of resistance by hydrolysing the beta-lactam
antibiotics [3]. These enzymes include class A carbapenemases like Klebsiella
pneumoniae carbapenemase (KPC), class B carbapenemases like Verona integron-
encoded metallo-beta-lactamase, New Delhi metallo-beta-lactamase (NDM-1),
imipenemase, and class D oxacillinases like OXA-48. Among them, OXA-
48-producing Enterobacteriaceae exist in Turkey endemically; metallo-
beta-lactamases like NDM-1 have also started to be encountered recently [4].
Although the molecular methods are considered to be the golden standard for
the detection of carbapenemase encoding genes, these are not adaptable to all
laboratories because of high cost and inaccuracy in the determination of new
resistance genes. Therefore, the application of economical and rapid diagnostic
screen tests has increased [5]. Rapid diagnosis of carbapenem-resistant isolates is
necessary for taking appropriate precautions against infection during the early period
and detection of the treatment procedure [6]. The most commonly used test is the
“Carbapenemase Nordmann–Poirel (CarbaNP)” test, which is reported to have 100%
sensitivity and speciﬁcity. The test is based on the hydrolysis of the beta-lactam ring
of a carbapenem, usually imipenem by bacterial lysate, which is determined by a
pH indicator [7, 8]. Another phenotypic test that is cost-effective with 100%
sensitivity and speciﬁcity is the “Carbapenem Inactivation Method (CIM).” It has
been reported to be an effective phenotypic test for the identiﬁcation of carbape-
nemase producers [9]. This study aimed to evaluate the performance of CarbaNP and
CIM tests in the isolates carrying the blaOXA-48 carbapenem resistance gene.
Materials and Methods
Detection of isolates
A total of 83 isolates obtained from the blood, urine, and tracheal aspirate
were sent to 29 Mayis State Hospital, Microbiology Laboratory, Ankara, Turkey
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between 1 August 2015 and 30 November 2016. In addition, 30 Enterobacter-
iaceae isolates with no reduced sensitivity against any carbapenem were
evaluated in this study. The isolates were identiﬁed using Matrix Assisted Laser
Desorption Ionization-Time of Flight Mass Spectrometry (Bruker Biotyper;
Bruker Daltonics, Bremen, Germany). The sensitivity of carbapenems, namely
imipenem, meropenem, and ertapenem, was studied using the gradient strip test
(Lioﬁlchem, Roseto degli Abruzzi, Italy). The results of the antibiotic suscepti-
bility test were evaluated according to EUCAST 2016 data [10].
Detection of carbapenem resistance genes
The existence of blaOXA-48 and blaNDM-1 genes was detected with the
polymerase chain reaction (PCR) method in the isolates displaying reduced
sensitivity against meropenem [11, 12].
CarbaNP test
The CarbaNP test was employed with slight changes in the original
protocol to detect the carbapenemase activity [13]. After 24 h of incubation
in the Mueller–Hinton agar, a 10-μL loop full of isolates was suspended in
100 μL of 20 mmol/L Tris-HCl lysis buffer (B-PERII, Bacterial Protein
Extraction Reagent; Thermo Scientiﬁc Pierce, USA), vortexed for 1 min
followed by incubation for 30 min at ambient temperature. The bacterial
suspension was centrifuged at ambient temperature for 5 min at 10,000 × g.
A small aliquot (100 μL) of the supernatant from each isolate was put into an
Eppendorf tube. A phenol red solution of 100 μL (pH 7.8) containing 0.1 mmol/
L ZnSO4 (Fluka, Germany) was prepared in another Eppendorf tube. A solution
of 6 mg/mL of imipenem/cilastatin and the phenol red solution were added into
the tubes containing the isolates. The phenol red solution was prepared by
mixing 2 mL of 0.5% (weight/volume) phenol red solution (Sigma, ABD) with
16.6 mL of distilled water followed by pH adjustment to 7.8 with 1N NaOH.
In lieu of the imipenem monohydrate used in the original protocol, a solution of
6 mg/mL of imipenem/cilastatin (Tienam, MSD) was used as reported in the
modiﬁed protocol [14]. The tubes were incubated for 2 h at 37 °C and evaluated
every 15 min. The change in the color from red to yellow was interpreted as
the positive result. The test was repeated three times for the isolates where the
resistance genotype was detected with the PCR method, but the test result was
found to be negative.
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CIM test
A loop full of colony was picked up from the sheep blood agar plate and
suspended in sterilized water. This was followed by the addition of 10 μg of
meropenem disk (Oxoid Ltd., Basingstoke, United Kingdom) to the bacterial
suspension and incubation at 35± 2 °C for 2 h. At the end of the incubation,
meropenem disk was placed on the plate on which 0.5 McFarland standard
Escherichia coli ATCC 25922 (0.5 McFarland dilution of E. coli ATCC 25922 in
5 mL of broth) was dispersed. The plates were incubated at 35± 2 °C for at least
6 h. At the end of the incubation period, the test was considered negative if the
meropenem disk preserved its effectiveness and a zone was formed, whereas it was
considered positive if a zone could not be formed around the meropenem disk
because of the loss of its effectiveness caused by carbapenemase activity [9]. The
test was repeated three times for the isolates in which the existence of resistance
genotype had been detected with PCR method, but the test showed a negative
result. K. pneumoniaeATCC BAA-1705 and K. pneumoniaeATCC 25955 strains
were used as positive and negative controls, respectively.
Statistical analysis
McNemar’s test was performed using SPSS for Windows (Version 17.0)
software. The level of signiﬁcance was deﬁned at p< 0.05.
Results
Identiﬁcation of isolates
Out of the total CPE isolates included in the study, 77 isolates (92.77%)
were identiﬁed as K. pneumoniae and six isolates (7.23%) were identiﬁed as
E. coli. Among the isolates with no reduced sensitivity against any carbapenem,
47 isolates (94%) were speciﬁed as K. pneumoniae, whereas three isolates were
identiﬁed (6%) as E. coli. It was determined that 74 isolates (89.16%) displayed
blaOXA-48 and nine isolates (10.84%) displayed both blaOXA-48 and blaNDM-1
resistance genotypes.
CarbaNP test results
The CarbaNP test was found to be positive for all the isolates associated with
OXA-48 and NDM-1. Among the isolates exhibiting positive result for OXA-48,
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nine isolates (13.04%) were determined as negative. The positivity of the CarbaNP
test according to resistance genotypes is given in Table I. The test was found
negative in all those isolates displaying no reduced sensitivity against any of the
carbapenems.
The sensitivity of the CarbaNP test was determined as 89.16%, and a
speciﬁcity of 100% in the isolates studied, whereas the positive and negative
predictive values of the test were detected to be 1.00 and 0.85, respectively.
The CarbaNP test yielded a positive result in the ﬁrst 15 min in 30 (40.54%)
isolates associated with OXA-48 and NDM-1 and 20 isolates producing only
OXA-48. The test displayed positive results in 1 h in the remaining 44 (59.46%)
OXA-48-producing isolates.
CIM test results
The CIM test was determined to be positive in all the isolates associated with
OXA-48 and NDM-1. It was observed that two of the isolates positive for OXA-48
(2.90%) were determined as false positive. The positivity of the CIM test according
to resistance genotypes is given in Table I. All the isolates were detected to be
positive by the end of 6 h. The negative isolates were incubated overnight, but the
result did not change. All the isolates displaying no reduced sensitivity against any
of the carbapenems were found to be negative by the CIM test.
The sensitivity of the CIM test in the isolates studied was determined to be
97.59%, and the speciﬁcity was found to be 100%. The positive and negative
predictive values of the test were detected as 1.00 and 0.96, respectively. We
observed that the CIM test has a slightly higher sensitivity than the CarbaNP test
(97.59% vs. 89.16%, respectively; p= 0.016).
Discussion
Rapid detection of CPE is important both for taking effective precautions
against the infection and for starting the appropriate treatment procedure [15].
Although molecular methods are considered to be the golden standard,
Table I. The allocation of the CarbaNP and CIM tests’ results of the isolates according to carbapenemase
resistance genotypes (n= 83)
Test OXA-48 (%) OXA-48 and NDM-1 (%) Total (%) Sensitivity Speciﬁcity
CarbaNP 60 (86.96) 14 (100) 74 (89.16) 89.16 100
CIM 67 (97.10) 14 (100) 81 (97.59) 97.59 100
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laboratories prefer to apply rapid, cost-effective, and easy-to-handle tests.
Furthermore, methods based on molecular approach are expensive, and the
infrastructure of every laboratory is not appropriate for these tests [9]. The
sensitivity and speciﬁcity of the phenotypic tests may differ depending on
the enzyme type, bacterial species, and expression level of the gene that codes
for the enzyme or carbapenem resistance, which may also arise from some non-
carbapenemase-producing isolates [15].
Various types of CPE have spread rapidly in Turkey. Although the oxacilli-
nases are endemic, other types of carbapenemase have also started to appear [16]. In
this study, we determined the performance of CarbaNP and CIM phenotypic tests in
the isolates carrying the OXA-48 enzyme, commonly observed in Turkey.
CarbaNP test is a simple and rapid test. However, the high cost of imipenem
sodium is a disadvantage for the test. The drugs, imipenem and cilastatin, are
inexpensive and do not cause variations in the test performance [17]. For this
purpose, we employed the modiﬁed protocol of the CarbaNP test in the study [14].
On the one hand, the sensitivity of the CarbaNP test was determined to be
89.16% and its speciﬁcity to be 100%. All false negative results (13.04%) were
detected in the isolates producing OXA-48 in the study. The test gave a positive
result in the ﬁrst 15 min in the isolates associated with blaOXA-48 and blaNDM-1
genes, whereas the test gave a positive result in 1 h in 59.46% of the isolates
carrying blaOXA-48 gene. The speciﬁcity was determined to be 100% in similar
studies conducted with CarbaNP test; the sensitivity value of the test ranged from
72.5% to 100% [8, 13, 18–20]. It is reported that the sensitivity of the CarbaNP test
is low, especially in the isolates carrying the blaOXA-48 gene [20, 21]. Moreover, it
is stated that the test gives a positive result later in the isolates carrying blaOXA-48
gene, particularly compared with the isolates containing KPC [13, 20]. Both the
low sensitivity level in the isolates and the detection of a positive result later are in
compliance with this study. We believe that a slightly lower sensitivity rate found
in this study compared with previous studies is due to the fact that only the isolates
producing OXA-48 were included in the study.
On the other hand, the sensitivity of the CIM test was detected to be higher
than the CarbaNP test (97.10%), whereas the speciﬁcity was found to be the same
(100%). The false negative result was detected in the isolates containing OXA-48
(2.90%) in the CIM test as well as in the CarbaNP (13.04%) test. Studies on the
evaluation of the performance of the CIM test in carbapenem-resistant Enter-
obacteriaceae species report that the sensitivity ranges from 98.8% to 100% and
the speciﬁcity is 100% [9, 22, 23]. Although the overnight incubation in the CIM
test is speciﬁed as the greatest disadvantage of the test, Bayramog˘lu et al. [23]
reported that the test could be concluded in 6 h. We also detected that all positive
results were obtained in 6 h.
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It is stated that the CarbaNP test gives false negative results, especially in the
mucoid colonies containing OXA-48 and NDM-1, whereas the CIM test may be
conﬁdently used in the clinical laboratories in spite of the need for a longer
incubation time [24].
Based on our investigation CarbaNP and CIM phenotypic tests are useful
tools in laboratories for the identiﬁcation of carbapenemase producers, especially
in the regions where OXA-48 is commonly observed. However, carbapenem
resistance genes need to be detected with the molecular methods in the suspicious
isolates with negative CarbaNP test result.
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